Jody L.Sindelar

Professor Jody Sindelar is a professor emerita of public health, a health economist, and a public policy expert in the Department of Health Policy and Management at Yale School of Public Health (YSPH), as well as with Yale’s Department of Economics. In addition, she is a research associate at the National Bureau of Economic Research (NBER), research fellow at the IZA Institute of Labor Economics, and faculty fellow at Yale’s Institution for Social and Policy Studies (ISPS). She is also a founding member and past president of the American Society of Health Economists (ASHEcon).

Professor Sindelar’s expertise is on the economics of substance abuse, including addictive substances of tobacco/vaping, alcohol, and illicit drugs. She has published on the impacts of substance abuse on productivity, educational attainment, gender differences, and other policy issues; and in various journals of economics, policy, addiction, health and medicine. Also, she has served on numerous editorial, review, and advisory boards and committees, and has presented her research at seminars and conferences both nationally and abroad. Professor Sindelar has given keynote addresses to conferences in the United States, Australia, Germany, Italy, and Sweden. She has also been a visiting professor at several universities and institutes, including Boston University in Boston, MA; the Rand Corporation in Santa Monica, CA and Washington, DC; Centro de Investigación y Docencia Económicas (CIDE) in Mexico City, Mexico; and Shanghai Jiao Tong University Medical School in Shanghai, China. In addition, she has had sabbaticals at the Institut d’études Politiques de Paris (Paris Institute of Political Studies) in Paris, France; Stanford University in Stanford, CA; and the University of Pennsylvania.

Professor Sindelar has been a principal investigator or collaborator on numerous research projects funded by various organizations, including the Agency for Healthcare Research and Quality (AHRQ); Centers for Medicare and Medicaid Services (CMS); Connecticut Department of Social Services (DSS); Food and Drug Administration (FDA); National Institute of Alcohol Abuse and Alcoholism (NIAAA); National Institute of Mental Health (NIMH); National Institute on Aging (NIA); National Institute on Drug Abuse (NIDA); Robert Wood Johnson Foundation (RWJF); Department of Veterans Affairs (VA); Yale Center for Clinical Investigation (YCCI); and the Federal Drug Administration.